{"name":"R-Pharm","slug":"r-pharm","ticker":"","exchange":"","domain":"","description":"R-Pharm is an international pharmaceutical company headquartered in Russia. It reached the headlines in September 2020 following approval of its drug \"Coronavir\" as a treatment in cases of mild to moderate COVID-19 infection. It was founded by Alexey Repik in 2001, but has had an increasingly international operations base since, with Japanese Corporation Mitsui & Co., Ltd. acquiring 10% of its shares in 2017. In 2022, against the background of the introduction of personal sanctions, Alexey Repik resigned from the owners of R-Pharm, selling his share in the company to the management of R-Pharm, and resigned as chairman of the board of directors.","hq":"","founded":2001,"employees":"N/A","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2007-01-01","label":"Ixempra Kit first approved","drug":"Ixempra Kit","drugSlug":"ixabepilone","type":"approval","sentiment":"positive"},{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":11,"colorKey":"oncology","drugs":[{"name":"RPH-075","genericName":"RPH-075","slug":"rph-075","indication":"Other","status":"phase_3"},{"name":"Tavanic","genericName":"Tavanic","slug":"tavanic","indication":"Other","status":"marketed"},{"name":"Concomitant treatment","genericName":"Concomitant treatment","slug":"concomitant-treatment","indication":"Other","status":"phase_3"},{"name":"Epothilone","genericName":"Epothilone","slug":"epothilone","indication":"Other","status":"phase_2"},{"name":"Odelepan","genericName":"Odelepan","slug":"odelepan","indication":"Other","status":"phase_3"},{"name":"Placebo (100 ml)","genericName":"Placebo (100 ml)","slug":"placebo-100-ml","indication":"Other","status":"phase_3"},{"name":"Placebo (250 ml)","genericName":"Placebo (250 ml)","slug":"placebo-250-ml","indication":"Other","status":"phase_3"},{"name":"RPH-002","genericName":"RPH-002","slug":"rph-002","indication":"Phase 3 for [insert indication here, if known]","status":"phase_3"},{"name":"Refralon","genericName":"Refralon","slug":"refralon","indication":"Other","status":"phase_2"},{"name":"Uritos®","genericName":"Uritos®","slug":"uritos","indication":"Hyperuricemia and gout prophylaxis","status":"phase_3"},{"name":"Urotol®","genericName":"Urotol®","slug":"urotol","indication":"Symptomatic treatment of overactive bladder","status":"phase_3"}]},{"name":"Oncology","slug":"oncology","revenue":0,"percentOfTotal":0,"drugCount":3,"colorKey":"cardiovascular","drugs":[{"name":"standard concomitant therapy","genericName":"standard concomitant therapy","slug":"standard-concomitant-therapy","indication":"Metastatic non-small cell lung cancer, PD-L1 positive","status":"phase_3"},{"name":"Ixabepilone + Capecitabine","genericName":"Ixabepilone + Capecitabine","slug":"ixabepilone-capecitabine","indication":"Metastatic or locally advanced breast cancer","status":"phase_3"},{"name":"Ixempra Kit","genericName":"IXABEPILONE","slug":"ixabepilone","indication":"Metastatic or locally advanced breast cancer with capecitabine","status":"marketed"}]},{"name":"Metabolic","slug":"metabolic","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"immunology","drugs":[{"name":"RPH-104","genericName":"RPH-104","slug":"rph-104","indication":"Type 2 diabetes","status":"phase_3"}]},{"name":"Infectious Disease","slug":"infectious-disease","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"neuroscience","drugs":[{"name":"Placebo Narlaprevir","genericName":"Placebo Narlaprevir","slug":"placebo-narlaprevir","indication":"Chronic hepatitis C virus (HCV) infection","status":"phase_3"}]},{"name":"Immunology","slug":"immunology","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"infectious","drugs":[{"name":"RPH-051","genericName":"RPH-051","slug":"rph-051","indication":"Psoriasis","status":"phase_3"}]}],"pipeline":[{"name":"RPH-075","genericName":"RPH-075","slug":"rph-075","phase":"phase_3","mechanism":"RPH-075 is a small molecule that targets the [insert target here, if known].","indications":[],"catalyst":""},{"name":"RPH-104","genericName":"RPH-104","slug":"rph-104","phase":"phase_3","mechanism":"RPH-104 is a small molecule that targets the SGLT2 receptor.","indications":["Type 2 diabetes"],"catalyst":""},{"name":"Tavanic","genericName":"Tavanic","slug":"tavanic","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"standard concomitant therapy","genericName":"standard concomitant therapy","slug":"standard-concomitant-therapy","phase":"phase_3","mechanism":"Standard concomitant therapy involves administering multiple medications together to treat a condition.","indications":["Metastatic non-small cell lung cancer, PD-L1 positive"],"catalyst":""},{"name":"Concomitant treatment","genericName":"Concomitant treatment","slug":"concomitant-treatment","phase":"phase_3","mechanism":"Concomitant treatment refers to the simultaneous administration of multiple therapeutic agents to enhance efficacy or address multiple disease pathways.","indications":[],"catalyst":""},{"name":"Epothilone","genericName":"Epothilone","slug":"epothilone","phase":"phase_2","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Ixabepilone + Capecitabine","genericName":"Ixabepilone + Capecitabine","slug":"ixabepilone-capecitabine","phase":"phase_3","mechanism":"Ixabepilone stabilizes microtubules to prevent cell division, while capecitabine is a prodrug that converts to fluorouracil to inhibit DNA synthesis, together providing synergistic cytotoxic activity against cancer cells.","indications":["Metastatic or locally advanced breast cancer","HER2-negative breast cancer"],"catalyst":""},{"name":"Ixempra Kit","genericName":"IXABEPILONE","slug":"ixabepilone","phase":"marketed","mechanism":"Ixempra Kit works by disrupting cell division, preventing cancer cells from growing and multiplying.","indications":["Metastatic or locally advanced breast cancer with capecitabine","Metastatic or locally advanced breast cancer as a single agent"],"catalyst":""},{"name":"Odelepan","genericName":"Odelepan","slug":"odelepan","phase":"phase_3","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Placebo (100 ml)","genericName":"Placebo (100 ml)","slug":"placebo-100-ml","phase":"phase_3","mechanism":"This drug has no known mechanism of action.","indications":[],"catalyst":""},{"name":"Placebo (250 ml)","genericName":"Placebo (250 ml)","slug":"placebo-250-ml","phase":"phase_3","mechanism":"This drug has no known mechanism of action.","indications":[],"catalyst":""},{"name":"Placebo Narlaprevir","genericName":"Placebo Narlaprevir","slug":"placebo-narlaprevir","phase":"phase_3","mechanism":"Narlaprevir is a protease inhibitor used to treat hepatitis C virus (HCV) infection.","indications":["Chronic hepatitis C virus (HCV) infection","HCV genotype 1 infection"],"catalyst":""},{"name":"RPH-002","genericName":"RPH-002","slug":"rph-002","phase":"phase_3","mechanism":"RPH-002 is a small molecule that targets the [insert target here, if known].","indications":["Phase 3 for [insert indication here, if known]"],"catalyst":""},{"name":"RPH-051","genericName":"RPH-051","slug":"rph-051","phase":"phase_3","mechanism":"RPH-051 is a selective inhibitor of phosphodiesterase 4 (PDE4) that reduces inflammatory mediator production by increasing intracellular cAMP levels.","indications":["Psoriasis","Atopic dermatitis"],"catalyst":""},{"name":"Refralon","genericName":"Refralon","slug":"refralon","phase":"phase_2","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Uritos®","genericName":"Uritos®","slug":"uritos","phase":"phase_3","mechanism":"Uritos is a uricosuric agent that increases urinary excretion of uric acid by inhibiting renal urate reabsorption.","indications":["Hyperuricemia and gout prophylaxis"],"catalyst":""},{"name":"Urotol®","genericName":"Urotol®","slug":"urotol","phase":"phase_3","mechanism":"Urotol is a muscarinic receptor antagonist used to treat overactive bladder.","indications":["Symptomatic treatment of overactive bladder"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMinwFBVV95cUxNdkFxLU52b3RESW5ib0VDaFp1cHJHUEduU0hBMzc3T0NhS01hTDcweUtIUDFvdGZuVXIzNkx2djJHemo0Vk54cmRneHV6Z0JMci1nSG5hQzk1eHl5eEZWUjVJQzkyY2EtZ1RKbmc3dnkzUFUyaEY2VDZIUnFuR2tlMG9XSWw4MXZ1TzJEZWY0WHZ4Rkxlb1dlNURKU0ZFM1XSAZ8BQVVfeXFMTXZBcS1Odm90REluYm9FQ2hadXByR1BHblNIQTM3N09DYUtNYUw3MHlLSFAxb3RmblVyMzZMdnYyR3pqNFZOeHJkZ3h1emdCTHItZ0huYUM5NXh5eXhGVlI1SUM5MmNhLWdUSm5nN3Z5M1BVMmhGNlQ2SFJxbkdrZTBvV0lsODF2dU8yRGVmNFh2eEZMZW9XZTVESlNGRTNV?oc=5","date":"2026-02-03","type":"pipeline","source":"Новости GxP","summary":"Production of Chinese medical equipment may be localized in Russia - Новости GxP","headline":"Production of Chinese medical equipment may be localized in Russia - Новости GxP","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikgFBVV95cUxNamREb05yYUNfNlg3bEdCa2kxdFRyZk9QTjhvbDI2ZE9jYVFadjJjaWNSWVJxRXZGN0owdFE2R0hiVVM4RU41S1hrMEZ4X3JYdG1JNDZQSy05RTBXWm03N1h0RmRPX1BacnJ3Nm9hWmZ3RjFFaXlmSlAtaERtQTgyTGxoeTdOazBpcHZ6Ny1MN3NVdw?oc=5","date":"2026-01-26","type":"pipeline","source":"The Sun Malaysia","summary":"R Pharmacy launches CNY campaign with celebrity music video - The Sun Malaysia","headline":"R Pharmacy launches CNY campaign with celebrity music video","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi0wFBVV95cUxQb3AxdU1rRDJpME90dGtDN2ZERTNoZkYxSGtvZUZ0V3c1a3pRQUxSeXlZYTJNcUJZQ05MYnpQV2FMT0dNNEFOYUlBLU11SEF5ZjNQYjBGWFI4djFKdTNLUWpyRFZqbjhZLVFPMUpia1duVGlmaWhxUkFSd2JMUU9YVUoweVEzZ0xaTGJNX2lyTHNRUHI1SERnUkJuSlJOanhFbTBLbVprNm9TWGw2bXlVbFppOUpPakI2YlRya0kyVmw1SUdpNnVrYmZUa2Eza1UwMWNv?oc=5","date":"2026-01-26","type":"pipeline","source":"BusinessToday Malaysia","summary":"R Pharmacy Broadens Community Pharmacy Role With Teleconsultation And Lifestyle-Led Outreach - BusinessToday Malaysia","headline":"R Pharmacy Broadens Community Pharmacy Role With Teleconsultation And Lifestyle-Led Outreach","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiWkFVX3lxTE43ay16U2RxemZUWUtqd1U1Mmh0aWdvS3l3cmZwcGJabkNTLWdMRVI3RndPZXlGYlZLajZFbkdqcXdNUlFaellGSEMzZEFGUmZTbExab056RFladw?oc=5","date":"2026-01-21","type":"pipeline","source":"Hitech Century","summary":"R Pharmacy redefines holistic and accessible healthcare experience in Malaysia with CNY MV showcase - Hitech Century","headline":"R Pharmacy redefines holistic and accessible healthcare experience in Malaysia with CNY MV showcase","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiygFBVV95cUxNLTdpenhoTXQ5UUc2X1ZqNnJNMl94bDBldjEyXzloVUllWHMwTnVBMHNwOVdKRUNubU05TE5VLTBQZUZiOXMyU2VxZ2Q0a3JEYUhxOWRWLWVUSTJRbERFNzdNcWJSVWxtcTViQjZWa3c2a1RXVlRLcFhGMkhkRHJoZmJnMXk4VXBVVW9TRkNuVE1QdXpSWmc5elUyUEhLZGlyVG5EdzBTb08xdU51cVdZTHVGMzdGY2U4NmJqUHRWWkpUWGVUeFRpUHJB?oc=5","date":"2025-12-08","type":"pipeline","source":"The Business Times","summary":"Malaysia’s retail pharmacy boom draws billion-ringgit bets as IPO pipeline builds - The Business Times","headline":"Malaysia’s retail pharmacy boom draws billion-ringgit bets as IPO pipeline builds","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMihwFBVV95cUxOb0luNXI1QlVQVjFaWlFyaTVjXzlPR28yYWx0b2tvX1RtMU1uaVJ2Nkl6NGZmcWNIczl0N1FJZFZnblJFWG1ZQ3JyQlJoNkM0RmNTVlZEay1rdEZSU2M1T2Vqd0lCS2JGZVhDbF9tYXVaaUVXeGlGb1REWFFzSjM1MHBCa3ZrUGfSAYcBQVVfeXFMTm9JbjVyNUJVUFYxWlpRcmk1Y185T0dvMmFsdG9rb19UbTFNbmlSdjZJejRmZnFjSHM5dDdRSWRWZ25SRVhtWUNyckJSaDZDNEZjU1ZWRGsta3RGUlNjNU9landJQktiRmVYQ2xfbWF1WmlFV3hpRm9URFhRc0ozNTBwQmt2a1Bn?oc=5","date":"2025-12-01","type":"pipeline","source":"Новости GxP","summary":"Taiwanese HIV drug to become available in Russia - Новости GxP","headline":"Taiwanese HIV drug to become available in Russia - Новости GxP","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikAFBVV95cUxPVGNSeVF3TnNNYmt1M3I0UHhoTkFSeS1kWk1hMUpIdmFURlNlbVdfdDdlelRZeWdCNUVSclZJbmdLNDlnQ0VhOFBFRmE0cnVXdzFCSnJCbDd0RWw2R2JiTERTQ3hZbFU1VTJiTTdnQ0RmMnBPU2RIQW5lNFJFclRObGZwa2xHUEZIcXM4cndwNTTSAZABQVVfeXFMT1RjUnlRd05zTWJrdTNyNFB4aE5BUnktZFpNYTFKSHZhVEZTZW1XX3Q3ZXpUWXlnQjVFUnJWSW5nSzQ5Z0NFYThQRUZhNHJ1V3cxQkpyQmw3dEVsNkdiYkxEU0N4WWxVNVUyYk03Z0NEZjJwT1NkSEFuZTRSRXJUTmxmcGtsR1BGSHFzOHJ3cDU0?oc=5","date":"2025-11-19","type":"pipeline","source":"Новости GxP","summary":"Export: What Russian Pharma Offers the World Drug Market - Новости GxP","headline":"Export: What Russian Pharma Offers the World Drug Market - Новости GxP","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqgFBVV95cUxNQnh6blRVRU5XOUQzNXNPcEpaRHpZNXcwUkZiQ1UxenhWX2NzSV9kVHR3Vk9Mc1JxODA2WEV5SE9ZbnpPLWVZRHFwRW5OWjBCN2gwREQtUEh2MFRkS3hHY0xJR3hCSWt1VU9QQS1lM2UxTWFISnJNTEtOTXpDWW9PclprSW0tc2VPZ0RFN0JWWWoxWVYwYUk0SFRRNnRMQVp6NTZiZXJIUjE1UQ?oc=5","date":"2025-11-02","type":"pipeline","source":"russia's pivot to asia","summary":"Russia’s R-Pharm To Invest US$200 Million Into Kazakh Pharmaceutical Factory - russia's pivot to asia","headline":"Russia’s R-Pharm To Invest US$200 Million Into Kazakh Pharmaceutical Factory - russia's pivot to asia","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiwAFBVV95cUxQQW5IYkgxaDRJV3BPVnFhTkM4aFhldzk2QXhVSEdSRHJFWlA5SUh4WHVyR0VLUEJqNnlXQzM2VTZVcTNoSjI1RXVIYWxOYWR2ckpLVThPbVlzZkNudnkyTnB2MGNON1JFUWxpVHZBMzJpSTJMeGtlemp0WndzUWxMSS0wSGxDTVFZdURjYXczR21Ka1dWTkJnMXQxQkMxb19YaFJxY1BRVHNvVV92MDBsNmpVTUQwS3JyQTd2MVB2dVQ?oc=5","date":"2025-08-26","type":"deal","source":"The Pharma Letter","summary":"Russian drugmaker R-Pharm searching buyers for its flagship factory in Germany - The Pharma Letter","headline":"Russian drugmaker R-Pharm searching buyers for its flagship factory in Germany","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMihwFBVV95cUxQM0FRR3AxWnkwdEJ4YjNOeGZKUE42WklQdVlhVnB3NFkwS3VzemhxbndpS1VRa3J3eW4xcV9EOXRKTWE0TUFYSklSWHhGSEdPdDNRbXhTRDdfZWc1MGI2OWtGTjBXOUZ6VVhPdTBFdUpIMEZyWVlUdXN0REpHaGVzOWJfbi12TDg?oc=5","date":"2025-08-15","type":"deal","source":"Yahoo Finance","summary":"Nutrishare Acquires Select Coram(R) Pharmacy Assets to Expand Services Nationwide and Open New Pharmacy in Arizona - Yahoo Finance","headline":"Nutrishare Acquires Select Coram(R) Pharmacy Assets to Expand Services Nationwide and Open New Pharmacy in Arizona","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitwFBVV95cUxNT1pOV0lrMzBTaGl1NGJ6M0I2WGluTzhJeHM2dnhZSmthMHZ6ai1EaWRwQ2pkY1F4Y0hEWDJSOGw1NWRReDlDeHV4Q211UU4xUk93LWsweEs0Y3JyT2wwNkM2eVJFdm5NMk1pclgyT1ZGTVhOSkkyX3B6RTJPTmx3WUpHRHZUWkFWOC1taFpmUnVhcFMzWUprQmFSak9XeUl3QnNGaThoX1lkbng5b3RuN0s0MVZhdG8?oc=5","date":"2025-08-05","type":"pipeline","source":"Reuters","summary":"Moscow-based pharma firm sues Raiffeisenbank for 337.5 million euros - Reuters","headline":"Moscow-based pharma firm sues Raiffeisenbank for 337.5 million euros","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMibEFVX3lxTE03QTBIZUQxMmItR0lERkRpcWZXZzVac09ubDJMek5MaldXNTktOGlPUEdHS01XRWNnRFhzZExaS0g0SUlsaWtNeVZKenJ2OF9TV3lYYUpaLTN1eHhQZVpVOTcyNjlVdlp6eHVjUw?oc=5","date":"2017-04-27","type":"pipeline","source":"mitsui.com","summary":"Mitsui to Participate in the Russian Pharmaceutical Company R-Pharm | 2017 | Releases - mitsui.com","headline":"Mitsui to Participate in the Russian Pharmaceutical Company R-Pharm | 2017 | Releases","sentiment":"neutral"}],"patents":[],"drugCount":17,"phaseCounts":{"phase_3":13,"marketed":2,"phase_2":2},"enrichmentLevel":2,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}